Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2007
11/28/2007CN100351372C Prolan enzyme bacterial and preparation process
11/28/2007CN100351271C Active polypeptide of brown-spotted torrential frog, its gene and application in drug preparation
11/28/2007CN100351270C Antibacterial peptide of brown-spotted torrential frog, its gene and application in drug preparation
11/28/2007CN100351269C Pseudomonas pseudoalcaligenes disinsection protein gene
11/28/2007CN100350973C Drug composition for curing disease produced from IL-6
11/28/2007CN100350970C 因子 Factor
11/27/2007US7301083 Rice hybrid XL730
11/27/2007US7301080 Inbred maize line PH8DB
11/27/2007US7301078 Soybean cultivar 26312034
11/27/2007US7301077 Soybean cultivar 26143837
11/27/2007US7301071 Method for the production of plant seed with modified fiber content and modified seed coat
11/27/2007US7301070 Plant fatty acid synthases and use in improved methods for production of medium-chain fatty acids
11/27/2007US7301069 Methods of protecting plants from pathogenic fungi and nematodes
11/27/2007US7301068 Nonhuman model animal of Th2-mediated hyperimmune response
11/27/2007US7301041 Bi-functional metallocenes, preparation process and use in the labeling or biological molecules
11/27/2007US7301017 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis
11/27/2007US7301016 Comprises nucleotide sequences coding enzymatic polypeptide for diagnosing and treating cell proliferative disorders; animal models
11/27/2007US7301015 probes, primers, and DNA chips
11/27/2007US7301014 Nucleic acid molecule encoding a novel estrogen receptor beta variant
11/27/2007US7301007 PRO4340 polypeptides
11/27/2007US7301005 Immunomodulatory peptides derived from heat shock proteins and uses thereof
11/27/2007US7300942 For therapy of a fungal infection
11/27/2007US7300922 Enhancing or inhibiting the biological activity of nucleic acid ligands by administrating a modulator, to change the binding of the nucleic acid ligand for its target or degrading or cleaving
11/27/2007US7300921 with antibiotic activity; made by cultivation of Amycolatopsis orientalis
11/27/2007US7300795 Optoinjection methods
11/27/2007US7300792 Comprises genes isolated from Photorhabdus luminescens are introduced into Saccharomyces cerevisiae bioluminescent yeast cells; oxidoreductases
11/27/2007US7300791 Nucleotide sequences coding polypeptide for use in the treatment heart injury and diabetic ulcer
11/27/2007US7300790 Transgenic animals expressing transdominant negative retroviral nucleic acids and proteins
11/27/2007US7300787 Lactobacillus strains and use thereof in fermentation for L-lactic acid production
11/27/2007US7300786 Using transgenic gramnegative bacteria as bioreactor for fermentation of histidine to be used in medicine, cosmetics and animal feeds
11/27/2007US7300784 cyanide resistant; cultured from rhodococcus; for producing 2-hydroxy-4-methylthiobutyroamide from hydroxy nitrile compounds
11/27/2007US7300782 Enhanced enzymatic polypeptide for use as component of cleaning compound; detergents; papermaking; textiles
11/27/2007US7300775 Genetic engineered nucleic acid promoter
11/27/2007US7300772 Bone morphogenic protein for use in the treatment of bone disorders; for use as wound healing agent
11/27/2007US7300767 DNA sequence for generating an assay for identifying plant enzyme inhibitors
11/27/2007US7300765 SC6 for diagnosis of cancers
11/27/2007US7300762 Introducing into a cell a nucleic acid molecule comprising a nucleotide sequence encoding a modified Green Fluorescent Protein (GFP) fused to a nucleotide sequence encoding a protein of interest; culturing; determining the cellular and/or extracellular localisation of protein by detecting fluorescence
11/27/2007US7300756 for covalent attachment of target molecules (nucleic acids) onto substrate; for production of activated slides for use in preparing microarrays; solid phase synthesis
11/27/2007US7300754 Identifying sequence variation in lipid metabolic pathway for use in diagnosis, prevention and treatment of cardiovascular and lipid metabolism disorders
11/27/2007US7300658 For use in vaccines
11/27/2007US7300657 Recombinant viral-based malaria vaccines
11/27/2007US7300656 Treatment of inflammatory bowel disease with IFN-gamma inhibitors
11/27/2007US7300655 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
11/27/2007US7300654 Method of treating corneal transplant rejection in high risk keratoplasty patients
11/27/2007US7300653 Method of treating corneal transplant rejection
11/27/2007US7300652 Contacting cell expressing kidney injury-molecule-1 (KIM-1) cell surface polypeptide with an effective amount of an isolated antibody or antigen-binding-fragment thereof that binds to the extracellular domain of the human KIM-1 polypeptide
11/27/2007US7300650 Reovirus for the treatment of neoplasia
11/27/2007CA2380872C Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
11/27/2007CA2353792C Mutants of rna polymerases with increased stability
11/27/2007CA2340728C Methods of treating hypertension and compositions for use therein
11/27/2007CA2303061C Lunasin peptides
11/27/2007CA2208751C Oil body proteins as carriers of high value proteins
11/27/2007CA2100616C Receptor identification method
11/27/2007CA1341562C Gene coded for interleukin-2 polypeptide, recombinant dna carrying the said gene, a living cell line possessing the recombinant dna, and method for producing interleukin-2 using the said cell
11/22/2007WO2007134325A2 Methods and compositions for protein production using adenoviral vectors
11/22/2007WO2007134272A2 Humanized models via targeted mtagenesis with zinc finger nuclease
11/22/2007WO2007134234A2 Methods and compositions for obtaining marker-free transgenic plants
11/22/2007WO2007134161A2 Compositions and methods for inhibiting expression of the pcsk9 gene
11/22/2007WO2007134122A2 Plant artificial chromosome platforms via telomere truncation
11/22/2007WO2007134014A2 Compounds and methods for modulating expression of gcgr
11/22/2007WO2007133797A2 Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
11/22/2007WO2007133789A2 Customer facing interface power cycling of wireless terminals
11/22/2007WO2007133776A2 Active delivery and flow redirection: novel devices and method of delivery of materials to patients
11/22/2007WO2007133084A1 Host cells and uses thereof in the microbial production of hydroxylated aromatics
11/22/2007WO2007132949A1 High secretion production method of protein
11/22/2007WO2007132947A1 Bcl-xL TRANSGENIC ANIMAL AND UTILIZATION OF THE SAME
11/22/2007WO2007132917A1 Phage-displaying single-chain antibody capable of recognizing non-reduced mannose residue
11/22/2007WO2007132891A1 Method of transferring substance into cell
11/22/2007WO2007132873A1 Freeze-dried product for transferring nucleic acid, oligonucleic acid or derivative thereof
11/22/2007WO2007132864A1 Method for detection of cancer, and kit for detection of cancer
11/22/2007WO2007132844A1 Method for detecting disease-related marker using gastric mucosal lavage fluid
11/22/2007WO2007132789A1 Method for production of cleistogamous rice and method for selection of cleistogamous rice
11/22/2007WO2007132760A1 Method for detecting or quantifying wheat endogenous dna and method for determining contamination rate of genetically modified wheat in test sample
11/22/2007WO2007132589A1 Primer set for detection of dekkera yeast or brettanomyces yeast
11/22/2007WO2007132555A1 Cell membrane-permeable peptide and utilization of the same in cell
11/22/2007WO2007132512A1 Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease
11/22/2007WO2007132358A2 Thermostable dna polymerase of the archaeal ampullavirus abv and its applications
11/22/2007WO2007132271A2 Method for the production of a type i interferon in a transgenic avian
11/22/2007WO2007132269A2 Dub3 as a cancer therapy target
11/22/2007WO2007132193A1 Modified vird2 protein and its use in improved gene transfer
11/22/2007WO2007132175A2 Inhibitors of hcap18/ll-37 for use in the treatment of breast cancer
11/22/2007WO2007132169A1 Mutant hsv, materials and methods for generation of mutant hsv
11/22/2007WO2007132096A2 System for transposing hyperactive recombinant derivatives of mos-1 transposon
11/22/2007WO2007132052A1 Vectors into which the c7l gene is inserted and use of said vectors in the production of vaccines and of compositions for gene therapy
11/22/2007WO2007132040A1 Transgenic plants with altered starch levels as a result of the variation of the activity of vegetable nudix that hydrolyse adp-glucose
11/22/2007WO2007131774A1 Polypeptide producing cells
11/22/2007WO2007131745A2 Method for the submerged cultivation of filamentous organisms
11/22/2007WO2007131720A1 Improved production of sphingoid bases using genetically engineered microbial strains
11/22/2007WO2007131654A2 Anti-inflammatory fusion protein
11/22/2007WO2007131495A2 Multimer for immunostimulation
11/22/2007WO2007131352A1 High-affinity antagonists of elr-cxc chemokines
11/22/2007WO2007131292A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor xi
11/22/2007WO2007131280A1 HEMATOPOIESIS AND REGULATION THEREOF BY ETS RELATED GENE (Erg)
11/22/2007WO2007131276A1 Enzymes for degrading herbicides
11/22/2007WO2007131274A1 Short interference ribonucleic acids for treating allegic diseases
11/22/2007WO2007113237A3 Plants having enhanced yield-related traits and a method for making the same
11/22/2007WO2007110608A3 Fermentation process for the production of ethanol
11/22/2007WO2007102140A3 A semliki forest virus replication competent vector with enhanced biosafety
11/22/2007WO2007101949A3 Human interferon-gamma (infgamma) variants
11/22/2007WO2007100384A3 Three frame cdna expression libraries for functional screening of proteins